Marie Alt

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Esma Saâda-Bouzid, Cécile Defaucheux, Andy Karabajakian et al. · Annals of Oncology · 2017 · 609 citations

Medicine, Oncology, Pharmacotherapy +16

First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors

Manuel Hidalgo, Maria Martinez‐García, Christophe Le Tourneau et al. · Clinical Cancer Research · 2017 · 102 citations

Medicine, Oncology, Pharmacology +17

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Lisa Belin, Maud Kamal, Cécile Mauborgne et al. · Annals of Oncology · 2016 · 84 citations · Full text

Medicine, Oncology, Pharmacology +15

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Medicine, Oncology, Pathology +17

Contrast-Enhanced Power and Color Doppler Ultrasonography of the Pancreas in Healthy and Diseased Cats

Nathalie Rademacher, Stefanie Ohlerth, G. Scharf et al. · Journal of Veterinary Internal Medicine · 2008 · 47 citations · Full text

Veterinary Medicine, Veterinary Clinical Sciences, Veterinary Diagnostic Imaging +17